When an infection spreads throughout the body and triggers a dangerous immune response, the race to save a life begins. Understanding how to treat systemic infection—commonly known as sepsis—is crucial, as every hour counts in preventing organ damage and death.

Fighting Back When Your Body Fights Too Hard

Systemic infection, most widely recognized in its severe form as sepsis, occurs when the body’s response to an infection becomes overwhelming and starts causing harm rather than healing. The main goal of treatment is to stop the infection from spreading further, support the organs that are struggling to function, and prevent the condition from progressing to septic shock—a life-threatening stage where blood pressure drops dangerously low and multiple organs can fail.^[1]

Treatment strategies depend heavily on how advanced the infection has become and which organs are affected. A person with early sepsis may need aggressive treatment in a regular hospital ward, while someone in septic shock will require intensive care with round-the-clock monitoring. The patient’s age, overall health, and any existing medical conditions like diabetes or kidney disease also shape the treatment approach.^[3]

Medical guidelines, including those from the Surviving Sepsis Campaign and the Infectious Diseases Society of America, have established standard protocols that hospitals follow. These protocols are designed to ensure that every patient receives rapid, coordinated care from the moment sepsis is suspected. Beyond these established treatments, researchers are actively testing new therapies in clinical trials, searching for ways to reduce the mortality rate and improve long-term recovery for survivors.^[11]

Standard Approaches to Treating Systemic Infection

The cornerstone of sepsis treatment is the rapid administration of antibiotics—medications that kill or stop bacteria from multiplying. Because doctors often don’t immediately know which specific bacteria is causing the infection, they begin with broad-spectrum antibiotics. These are powerful medications that work against many different types of bacteria at once. Administered through an intravenous line (IV), these antibiotics enter the bloodstream quickly and can reach infected tissues throughout the body within minutes.^[7]

Medical guidelines strongly recommend that antibiotics be given within one to six hours of arriving at the hospital, though there is debate about the exact timing. Some research suggests starting within three hours of presentation, while the latest guidelines push for treatment within the first hour. Studies consistently show that each hour of delay can increase the risk of death by approximately 7.6 percent, making speed absolutely critical.^[15]

Common antibiotics used in early sepsis treatment include imipenem, meropenem, piperacillin-tazobactam, and moxifloxacin. Once blood culture results identify the exact bacteria causing the infection—usually within 24 to 48 hours—doctors can switch to more targeted antibiotics. This approach reduces unnecessary exposure to multiple medications and helps prevent the development of antibiotic-resistant bacteria.^[12]

Fluid resuscitation is equally vital in the early management of sepsis. When the body’s inflammatory response becomes dysregulated, blood vessels can leak fluid, and blood pressure drops. This reduces oxygen delivery to vital organs like the kidneys, brain, and heart. To counteract this, healthcare providers administer large volumes of intravenous fluids. The standard protocol calls for 30 milliliters of crystalloid fluids—such as normal saline—per kilogram of body weight within the first three hours.^[9]

Crystalloid fluids are water-based solutions containing minerals like sodium. They dissolve quickly and help restore blood volume rapidly. While other types of fluids exist, such as colloids like albumin or dextran, crystalloids are typically preferred because they are less expensive and equally effective for initial resuscitation. Healthcare teams carefully track the amount of fluid given and monitor the patient’s response through frequent measurements of blood pressure, heart rate, and urine output.^[15]

When fluid administration alone cannot restore adequate blood pressure, doctors turn to vasopressor medications. These are drugs that tighten blood vessels and help push blood to vital organs. Norepinephrine is the first-line vasopressor for septic shock. It works by stimulating receptors in blood vessel walls, causing them to constrict and blood pressure to rise. The goal is to maintain a mean arterial pressure of at least 65 millimeters of mercury (mm Hg), which ensures sufficient blood flow to organs. Other vasopressors, such as vasopressin or epinephrine, may be added if norepinephrine alone isn’t enough.^[14]

Patients with severe sepsis or septic shock often require additional support for failing organs. If the lungs cannot provide enough oxygen, a ventilator—a breathing machine—may be necessary. This device delivers oxygen-rich air directly into the lungs through a tube inserted into the windpipe. If the kidneys stop filtering waste from the blood, continuous renal replacement therapy, a type of dialysis, can take over this function. For the most critically ill patients, extracorporeal membrane oxygenation (ECMO) provides life support by pumping and oxygenating blood outside the body.^[15]

In some cases, surgery becomes necessary. If the source of infection is an abscess, an infected appendix, or damaged tissue, surgeons may need to remove these areas to stop the infection from spreading. For example, a patient with appendicitis that has led to sepsis would require an appendectomy. Surgical removal of infected tissue, known as debridement, is sometimes the only way to eliminate the bacteria feeding the sepsis response.^[7]

Throughout treatment, healthcare providers closely monitor lactate levels in the blood. Lactate is a substance produced when cells don’t get enough oxygen. High lactate levels indicate that organs are suffering from poor blood flow. Guidelines recommend measuring lactate every four to six hours until levels normalize, as studies show that lactate-guided resuscitation reduces overall mortality compared to no monitoring.^[14]

The duration of antibiotic therapy varies depending on the source of infection and how quickly the patient improves. Most bacterial infections causing sepsis require seven to ten days of treatment, though some severe cases may need longer courses. Doctors assess the patient’s temperature, white blood cell count, organ function, and overall clinical improvement to decide when it is safe to stop antibiotics.^[9]

Hospital stays for sepsis patients can range from several days to multiple weeks, depending on the severity and complications. Patients typically spend time in an intensive care unit (ICU) where specially trained nurses and doctors can provide constant monitoring and adjust treatments minute by minute. Even after leaving the ICU, many patients need further recovery time in a regular hospital room before being discharged home.^[10]

Side Effects and Challenges of Standard Treatment

While these treatments save lives, they can also cause side effects. Broad-spectrum antibiotics can disrupt the natural balance of bacteria in the gut, leading to diarrhea or secondary infections like Clostridium difficile colitis. Prolonged use of antibiotics also contributes to antimicrobial resistance, where bacteria evolve and become harder to kill. This is why doctors try to narrow antibiotic therapy as soon as possible based on culture results.^[7]

Vasopressor medications, while essential for maintaining blood pressure, can reduce blood flow to the fingers, toes, and skin, potentially causing tissue damage in severe cases. Large volumes of intravenous fluids can sometimes accumulate in the lungs or other tissues, causing swelling and breathing difficulties. Mechanical ventilation, though life-saving, can lead to lung injury or infections like ventilator-associated pneumonia if needed for extended periods.^[15]

Patients in the ICU may experience confusion, agitation, or even hallucinations due to a combination of factors including the illness itself, medications like sedatives and painkillers, lack of sleep, and constant noise and stimulation. This condition, called ICU delirium, can be distressing for both patients and families. Healthcare teams work to minimize sedation when possible and help orient patients by explaining where they are and what is happening.^[15]

Exploring New Treatments in Clinical Research

Despite advances in sepsis care, mortality rates remain stubbornly high—between 20 and 36 percent of patients with sepsis die, and the rate climbs even higher in septic shock. This has driven researchers around the world to investigate innovative therapies that could improve outcomes. Many of these experimental treatments are being tested in clinical trials at medical centers in the United States, Europe, and other regions.^[11]

One promising area of research focuses on modulating the immune system. Traditional thinking held that sepsis resulted from an overly aggressive immune response. However, recent studies by researchers like Dr. Richard Hotchkiss at Washington University in St. Louis have revealed that the picture is more complex. While some aspects of the immune system become overactive early in sepsis, other critical immune cells become depleted or dysfunctional. This leaves patients vulnerable not only to the initial infection but also to secondary infections that can be equally deadly.^[18]

To address this problem, Dr. Hotchkiss’s team has been testing a therapy using interleukin-7 (IL-7), a naturally occurring molecule that stimulates the production and function of certain white blood cells called lymphocytes. In a clinical trial called IRIS-7, researchers administered IL-7 to septic shock patients and found they could successfully increase lymphocyte counts. The therapy appeared safe and well-tolerated. The next phase of research will determine whether boosting these immune cells actually improves survival rates and reduces the risk of secondary infections.^[18]

This type of immunotherapy represents a fundamentally different approach to treating sepsis. Rather than simply fighting the infection with antibiotics, these therapies aim to restore the body’s own ability to fight off invaders. If successful, such treatments could reduce the long-term complications that many sepsis survivors face, including persistent weakness and susceptibility to infections.^[11]

Another avenue of investigation involves targeting the inflammatory cascade more precisely. Sepsis triggers the release of cytokines—signaling molecules that coordinate the immune response. In sepsis, this cytokine release can spiral out of control, creating what’s often called a “cytokine storm.” Researchers are testing medications that can dampen specific parts of this inflammatory response without completely shutting down the immune system. The challenge is finding the right balance: reducing harmful inflammation while preserving the body’s ability to fight the infection.^[11]

Some clinical trials are examining corticosteroids—anti-inflammatory hormones naturally produced by the adrenal glands—as a potential treatment. Although doctors don’t fully understand why, corticosteroids seem to help some sepsis patients by reducing inflammation and supporting blood pressure. However, results from different studies have been mixed, and not all patients benefit. Researchers are working to identify which patients are most likely to respond to corticosteroid therapy and what doses and timing work best.^[15]

Scientists are also developing better ways to diagnose and monitor sepsis. Early identification is crucial, but the current diagnostic criteria—known as the Sequential Organ Failure Assessment (SOFA) score—require laboratory tests that take time. Researchers are exploring the use of artificial intelligence and machine learning to predict which patients with infections are most likely to develop sepsis. By analyzing patterns in vital signs, laboratory values, and other data, these computer systems could alert doctors to high-risk patients before sepsis becomes severe.^[18]

Novel diagnostic tools are also being tested. Biomarkers—substances in the blood that change when sepsis is present—could provide faster and more accurate diagnosis. One such biomarker is procalcitonin, a protein that rises during bacterial infections. Some studies suggest that measuring procalcitonin levels can help doctors decide when to start or stop antibiotics, potentially reducing unnecessary antibiotic use and the development of resistance.^[14]

Future research is also focusing on improving long-term outcomes for sepsis survivors. Many patients who survive the initial infection face ongoing problems including physical disability, cognitive impairment (trouble with memory and thinking), depression, anxiety, and poor quality of life. Some develop post-sepsis syndrome, which can include extreme fatigue, difficulty sleeping, frequent illnesses, nightmares, and post-traumatic stress disorder (PTSD). These symptoms can persist for months or even years after leaving the hospital.^[10]

Clinical trials are investigating rehabilitation programs and supportive therapies that might help patients recover more fully. Some studies are looking at whether early physical therapy in the ICU can reduce long-term muscle weakness and disability. Others are exploring psychological support programs to help patients cope with the trauma of severe illness. The goal is not just to help patients survive sepsis, but to help them return to their previous level of function and quality of life.^[16]

Researchers are also studying why some patients develop sepsis while others with similar infections do not. Genetic factors may play a role, as some people’s immune systems may be more prone to overreacting to infections. Understanding these differences could eventually lead to personalized treatment approaches, where therapy is tailored to each patient’s unique genetic and biological profile.^[11]

Many of these clinical trials are being conducted at academic medical centers and hospitals with specialized sepsis programs. Patients who meet eligibility criteria—often including having sepsis or being at high risk for developing it, and not having certain other medical conditions that would make the trial unsafe—may be invited to participate. Participating in a clinical trial gives patients access to cutting-edge treatments while contributing valuable information that could help future patients.^[11]

Most Common Treatment Methods

• Antibiotic Therapy
  • Broad-spectrum antibiotics are given intravenously within one to six hours of suspected sepsis
  • Common agents include imipenem, meropenem, piperacillin-tazobactam, and moxifloxacin
  • Therapy is narrowed based on blood culture results to target the specific bacteria causing infection
  • Treatment typically lasts seven to ten days but may be extended depending on patient response
• Fluid Resuscitation
  • Intravenous crystalloid fluids (normal saline) are administered at 30 mL per kilogram of body weight within the first three hours
  • Fluids help restore blood volume and maintain blood pressure
  • Healthcare teams monitor the patient’s response through vital signs and urine output
• Vasopressor Medications
  • Norepinephrine is the first-line vasopressor used when fluid resuscitation alone cannot restore adequate blood pressure
  • These medications tighten blood vessels to improve blood flow to vital organs
  • The goal is to maintain mean arterial pressure at or above 65 mm Hg
• Organ Support
  • Mechanical ventilation provides breathing support when lungs cannot deliver adequate oxygen
  • Continuous renal replacement therapy (dialysis) supports failing kidneys
  • Extracorporeal membrane oxygenation (ECMO) provides life support for the most critically ill patients
• Surgical Intervention
  • Removal of infected tissue (debridement) may be necessary to stop infection from spreading
  • Surgery to drain abscesses or remove infected organs like the appendix
• Immunotherapy (Experimental)
  • Interleukin-7 (IL-7) is being tested to boost depleted immune cells in septic shock patients
  • Aims to restore the body’s ability to fight infections rather than just treating with antibiotics
  • Currently in clinical trials to determine effectiveness in improving survival
• Corticosteroids
  • Anti-inflammatory hormones that may help some sepsis patients by reducing inflammation and supporting blood pressure
  • Use is not universal as results vary between patients
  • Ongoing research to identify which patients benefit most